Patient Guide: A Study of TCD601 (siplizumab) in New Onset Type 1 Diabetes Patients

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 26 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06025110
Status: ACTIVE_NOT_RECRUITING
Condition: Diabetes Mellitus, Type 1
Phase: PHASE2

Find a Study Location Near You

This study is available at 26 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Brussel,
  • Leuven,
  • Catanzaro,
  • • And 23 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily